Loading news...
Citigroup Inc. increased its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 190.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 549,769 shares of the real estate investment trust's stock after acquiring an additional 360,619 shares during the
Sabra Health Care remains a Buy, supported by strong SHOP expansion, robust guidance, and a sustainable 5.84% dividend yield. SBRA projects 4.9%-5.4% FFO growth and plans over $450 million in investments for 2026, with a solid pipeline and a good debt schedule. Leverage is steady at 5x, with recent refinancing extending maturities and reducing interest costs, supporting financial flexibility.
Assetmark Inc. increased its position in Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 70.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 66,736 shares of the real estate investment trust's stock after buying an additional 27,520 shares
Rhumbline Advisers lessened its stake in Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 5.8% during the undefined quarter, according to its most recent disclosure with the SEC. The institutional investor owned 824,077 shares of the real estate investment trust's stock after selling 50,284 shares during the quarter. Rhumbline Advisers owned approximately 0.34% of
Sabra Healthcare REIT (NASDAQ: SBRA) executives told investors the company expects continued growth in 2026, citing improving senior housing operating fundamentals, steady leverage, and what management described as a robust investment pipeline that should exceed 2025 volume. 2026 outlook centers on SHOP growth and transition facility improvement CEO Rick Matros said net operating income (NOI) growth
Sabra Health Care REIT, Inc. (SBRA) Q4 2025 Earnings Call Transcript
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #CITI--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer; Michael Costa, the company's Chief Financial Officer; Darrin Smith, the company's Chief Investment Officer; and Lukas Hartwich, the company's Executive Vice President of Finance, will attend Citi's 2026 Global Property CEO Conference on March 1-4, 2026, at The Diplomat Beach Resort in Hollywood, Florida. About Sabra Sabra Health Care REI.
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #4Q25--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2025. FOURTH QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2025 were as follows: Net Income: $0.11 FFO: $0.36 Normalized FFO: $0.36 AFFO: $0.37 Normalized AFFO: $0.38 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.38x Senior Housing - Leased: 1.52x Beh.
NAV Monitor: U.S. REITs End January At Median 16.2% Discount To Net Asset Value
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #4Q25--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2025 fourth quarter earnings release on February 12, 2026, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 fourth quarter results will be held on Friday, February 13 at 11:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference.
Cornerstone Wealth Management LLC boosted its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 256.6% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 39,781 shares of the real estate investment trust's stock after purchasing an additional 28,625 shares during
Sabra Health Care REIT is rated Buy, with substantial upside driven by its accelerated transition to the SHOP operating model and attractive valuation. SBRA targets 40% SHOP portfolio exposure, expecting to exceed their up to $500M investment guidance, positioning for robust growth into 2026. Normalized AFFO guidance for 2025 is $1.495/share, with an 80% payout ratio supporting a 6.38% dividend yield and potential for future increases.
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #2025tax--Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced today the tax treatment for its 2025 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid: Sabra Health Care REIT, Inc. Common Stock (CUSIP # 78573L106) Record Date Payable Date Distribution per Share Total Ordinary Dividends Non-Qualified Dividends Qualified Dividends Non-Dividend Distributions 02/14/2025 02/28/2025 $ 0.3000000 $ 0.2438846 .
Sabra Healthcare REIT, Inc. (NASDAQ: SBRA - Get Free Report) has been assigned an average recommendation of "Hold" from the nine ratings firms that are covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year
TUSTIN, Calif.--(BUSINESS WIRE)---- $CIO #CIO--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced that Darrin Smith has been appointed Sabra's Chief Investment Officer, Secretary and Executive Vice President, effective January 1, 2026. Mr. Smith succeeds Talya Nevo-Hacohen, Sabra's former Chief Investment Officer, Treasurer and Executive Vice President in connection with her retirement on December 31, 2025. From March 2020 until his appointment as Chief Investment Officer, Mr. Smith served.
My update on Sabra Health Care REIT upgrades it to a strong buy. Although technical indicators point to a hold, several fundamentals drive the needle into the highly bullish range, particularly portfolio growth and macro demand in this niche of senior care. AFFO dividend coverage is adequate, though the payout ratio is slightly elevated at around 81%.
Sabra Health Care REIT presents a compelling value-income opportunity, offering a 6.4% yield and robust fundamentals. SBRA's SHOP segment drives growth, with same-store NOI up 13.3% and significant new investments targeting a 40% SHOP NOI mix. It received an investment-grade rating, has safe leverage, and has no debt maturities until 2027, supporting dividend safety.
Edgestream Partners L.P. lowered its holdings in Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 39.4% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 94,748 shares of the real estate investment trust's stock after selling 61,648 shares during the period.
Sabra Healthcare REIT (NASDAQ: SBRA - Get Free Report) and Park Hotels and Resorts (NYSE: PK - Get Free Report) are both mid-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability. Analyst Recommendations This is
The REIT sector has seen back-to-back tough months as it saw a modest average negative total return in September (-0.73%) and fell deeper into the red in October (-4.03%). Small cap REITs (-5.05%) had the worst performance in October. Micro caps (-2.81%), mid caps (-3.11%) and large caps (-4.45%) were also in negative territory albeit to a smaller degree. Only 21.66% of REIT securities had a positive total return in October.